Meta‐analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment

Aliment Pharmacol Ther 2010; 32: 1069–1079 Summary Background Problems with currently recommended Helicobacter pylori eradication therapies include unsatisfactory eradication rates and/or therapy‐associated side effects. Aim To investigate the effects of Saccharomyces boulardii as supplementation...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Alimentary pharmacology & therapeutics 2010-11, Vol.32 (9), p.1069-1079
Hauptverfasser:	Szajewska, H., Horvath, A., Piwowarczyk, A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - adverse effects Bacterial diseases Bacterial diseases of the digestive system and abdomen Biological and medical sciences Children Clinical trials Diarrhea Diarrhea - chemically induced Diarrhea - prevention & control Digestive system Drug Therapy, Combination Gastroenterology. Liver. Pancreas. Abdomen Helicobacter Infections - drug therapy Helicobacter pylori Helicobacter pylori - drug effects Human bacterial diseases Humans Infection Infectious diseases Language Medical sciences Pharmacology. Drug treatments Probiotics - therapeutic use Randomized Controlled Trials as Topic Reviews Risk assessment Saccharomyces - metabolism Saccharomyces boulardii Side effects Supplementation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!